MK2: a novel molecular target for anti-inflammatory therapy
The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Mitogen-activated protein kinase (MAPK)-activated protein kinase 2 (MK2) is activated upon stress by p38 MAPK. MK2 is stimulated in a wide range of inflammatory conditions and its catalytic activity is required for cytokine production, cell migration and is a potential drug target for inflammatory diseases. Disruption of MK2 leads to a reduction in TNF-alpha production. MK2-mediated pro-inflammatory cytokine production has been demonstrated in several inflammatory conditions where TNF-alpha plays a role. OBJECTIVE/METHODS: We discuss the development of specific MK2 inhibitors for the treatment of inflammatory diseases. RESULTS/CONCLUSION: Inhibition of the p38 MAPK pathway may have therapeutic uses for inflammatory diseases. However, blocking p38 MAPK activation in vivo is not advisable due to toxicity, significant off-target effects, and lack of oral bioavailability. This concern may be countered by the use of MK2 inhibitors that can dissect the pathways downstream of p38 without affecting additional cellular functions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The DNA damage response: putting checkpoints in perspective
Zhou, B.-B. S., & Elledge, S. J. (2000) · Nature · doi:10.1038/35044005 · Cited by 3,213
The p53 pathway: positive and negative feedback loops
Harris, S. L., & Levine, A. J. (2005) · Oncogene · doi:10.1038/sj.onc.1208615 · Cited by 1,967 · cited 1×
“The tumor suppressor protein p53 is a major downstream effector of these DNA-damage pathways [98] .”
BackgroundFridman, J. S., & Lowe, S. W. (2003) · Oncogene · doi:10.1038/sj.onc.1207116 · Cited by 1,401 · cited 1×
“If the DNA damage is extensive, then p53-dependent pathway targets the damaged cells for apoptosis through both the intrinsic and extrinsic pathways [100,101] .”
BackgroundMAPKAP kinase 2 is essential for LPS-induced TNF-α biosynthesis
Kotlyarov, A., Neininger, A., Schubert, C., Eckert, R., Birchmeier, C., Volk, H.-D., & Gaestel, M. (1999) · Nature Cell Biology · doi:10.1038/10061 · Cited by 763 · cited 5×
“Recent studies suggest that post-transcriptional control is accomplished by AU-rich elements (ARE) located at the 3 ′ UTR of several cytokines (IL-6, IL-8 and TNFα ) [7] and shown to play a crucial role in mRNA stability, transport and protein translation.”
BackgroundInfluentialScavenger Receptors in Atherosclerosis: Beyond Lipid Uptake
Moore, K. J., & Freeman, M. W. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000229218.97976.43 · Cited by 562 · cited 1×
“It is most probably attributable to an impaired uptake of modified atherogenic lipoproteins [93] .”
BackgroundMAPKAP kinases — MKs — two's company, three's a crowd
Gaestel, M. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1834 · Cited by 413 · cited 1×
“1 Primary structure Genome analysis shows that the catalytic domain and C -terminal regulatory part of MK2 are conserved in worms, fruit flies and mammals, whereas the N -terminal prolinerich region is only present in vertebrates [12] .”
BackgroundMicroglia and inflammatory mechanisms in the clearance of amyloid β peptide
Rogers, J., Strohmeyer, R., Kovelowski, C. J., & Li, R. (2002) · Glia · doi:10.1002/glia.10153 · Cited by 381
Koistinaho, M., Kettunen, M. I., Goldsteins, G., Keinänen, R., Salminen, A., Ort, M., Bures, J., Liu, D., Kauppinen, R. A., Higgins, L. S., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.032670899 · Cited by 159
Molecular basis of MAPK-activated protein kinase 2:p38 assembly
White, A., Pargellis, C. A., Studts, J. M., Werneburg, B. G., & Farmer, B. T. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701679104 · Cited by 111 · cited 1×
“Further studies demonstrated that in these interactions, the I366 – A390 of MK2, which also includes its nuclear localization signal, binds to the p38-docking region, confirming the involvement of the non-catalytic regions of MK2 in the tight binding of the MK2:p38 complex formation [22] .”
BackgroundCrystal Structure of the P38α-MAPKAP Kinase 2 Heterodimer
Haar, E. T., Prabakhar, P., Liu, X., & Lepre, C. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611165200 · Cited by 100 · cited 1×
“’ The C -terminal regulatory domain of MK2 binds in the docking groove of p38 and the ATP-binding sites of both kinases are at the heterodimer interface, and form extensive intermolecular interactions [21] .”
Background
Cited by
MK2 Phosphorylates RIPK1 to Prevent TNF-Induced Cell Death
Jaco, I., Annibaldi, A., Lalaoui, N., Wilson, R., Tenev, T., Laurien, L., Kim, C., Jamal, K., Wicky John, S., Liccardi, G., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.05.003 · Cited by 320
Alimbetov, D., Davis, T., Brook, A. J. C., Cox, L. S., Faragher, R. G. A., Nurgozhin, T., Zhumadilov, Z., & Kipling, D. (2016) · Biogerontology · doi:10.1007/s10522-015-9610-z · Cited by 162
MacKenzie, K. F., Wallace, D. A., Hill, E. V., Anthony, D. F., Henderson, D. J. P., Houslay, D. M., Arthur, J. S. C., Baillie, G. S., & Houslay, M. D. (2011) · Biochemical Journal · doi:10.1042/bj20101184 · Cited by 65
Therapeutic Effect of MK2 Inhibitor on Experimental Murine Dry Eye
Wu, Y., Bu, J., Yang, Y., Lin, X., Cai, X., Huang, C., Zheng, X., Ouyang, W., Li, W., Zhang, X., et al. (2017) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.17-22240 · Cited by 12
“inflammatory diseases, such as arthritis, atherosclerosis, and cancer.(26) In this study, we present evidence that topical application of MK2i eye drops could effectively alleviate epithelial damage, reduce cell apoptosis, and suppress CD4þ T-cell–mediated inflammation in the ocular surface in an experimental murine m…”
Background
Metadata
- Authors
- Duraisamy, S., Bajpai, M., Bughani, U., Dastidar, S. G., Ray, A., & Chopra, P.
- Venue
- Expert Opinion on Therapeutic Targets
- Publisher
- Informa UK Limited
- Published
- 2008-07-12
- Volume
- 12
- Issue
- 8
- Pages
- 921-936
- ISSN
- 1472-8222 (ISSN-L)
- 1744-7631
- OpenAlex
- W2161383908
- Cited by
- 73
- References
- 12
- FWCI
- 1.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: MK2: a novel molecular target for anti-inflammatory therapy. https://app.cochat.ai/papers/10.1517/14728222.12.8.921
- The paper
- Duraisamy, S., Bajpai, M., Bughani, U., Dastidar, S. G., Ray, A., & Chopra, P. (2008). MK2: a novel molecular target for anti-inflammatory therapy. Expert Opinion on Therapeutic Targets. https://doi.org/10.1517/14728222.12.8.921
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.